Medical Devices

Allergan’s Lap-Band Gains 26 Million More Customers

1 Mins read

The decision by the FDA to allow the use of lap-band for the management of obesity in patients with a lower body mass index (BMI) than previously was the case now means that Allergan effectively gains 26 million new prospective customers. The previous requirement for patients to qualify for the lap-band procedure was that they had a BMI of 40 or higher, or if they had a BMI of 35 or higher with at least one weight-related condition like diabetes or blood pressure. The new requirement is that patients have a BMI of at least 30 with one weight-related condition (or just 40 or higher). See below for calculation of BMI.

Body Mass Index (BMI)

Formula: weight (lb) / [height (in)]2 x 703

Calculate BMI by dividing weight in pounds (lbs) by height in inches (in) squared and multiplying by a conversion factor of 703.

(See Report #S835 for discussion of an alternative measure, Body Volume Index, a potentially more accurate measure of obesity, which may ultimately replace BMI.) The result is that while previously only 15 million Americans qualified for the Lap-Band, now 41 million qualify. This is a rather significant jump in Allergan’s prospects, and its stock price, which was dinged in January by reported links between breast implants and a rare form of breast cancer, anaplastic large cell lymphoma.  

Avatar
183 posts

About author
I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses. Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.
Articles
Related posts
Medical Devices

How Medical Equipment Leasing Helps Hospitals Stay On The Cutting Edge Of Tech

2 Mins read
To provide high-quality healthcare services to your patients, having cutting edge technology and equipment is critical. While purchasing new or upgraded equipment…
Medical DevicesTechnology

The Important And Powerful Role Of Portable Oxygen Concentrators

3 Mins read
  When it comes to life-changing technological advancements, it is fair to say that there have been many incredible innovations that have…
Medical DevicesSenior Care

3 Promising New Medical Alert System Technologies To Know About

2 Mins read
  Medical alert systems have long been associated with senior safety. However, in the last 5 years, medical alert technologies have exploded…